Navigation Links
Anti-Convulsant Aids Knee-Replacement Patients
Date:10/15/2007

Pregabalin reduced pain, increased range of motion, study found

MONDAY, Oct. 15 (HealthDay News) -- The anti-convulsant drug pregabalin, given before and after surgery, helped reduce pain and promote mobility in patients having total knee replacement.

That study finding was presented Sunday at the annual meeting of the American Society of Anesthesiologists, in San Francisco.

The study, funded by drug maker Pfizer Inc., included 60 total knee replacement patients who were divided into two groups. One group received 300 milligrams of pregabalin two hours before surgery and 150 mg twice a day for 14 days after surgery. Patients in the other group received a placebo.

All the patients received pain medication through an epidural catheter during surgery and through a patient-controlled device after surgery.

In the 32 hours after surgery, patients who received pregabalin reported lower levels of pain and used less pain medication. Patients in the pregabalin group also had a higher range of knee motion when they were discharged from the hospital -- 84 degrees versus 76 degrees for patients in the placebo group. A knee-motion range of at least 83 degrees is required to climb stairs.

"When you can walk up and down stairs, it makes a huge difference in patient quality of life," and improved range of motion also promotes quicker completion of post-surgery rehabilitation, said study author Dr. Asokumar Buvanendran, director of orthopedic anesthesia and associate professor of anesthesiology at Rush University Medical Center in Chicago.

More information

The American Academy of Orthopaedic Surgeons has more about total knee replacement.



-- Robert Preidt



SOURCE: American Society of Anesthesiologists, news release, Oct. 14, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Mode Of Action Of The Anti-Convulsant Valproate
2. One in Three Heart Attack Patients Have No Chest Pains
3. Amphetamines Help Recovery of Stroke Patients
4. Painkillers Do Not Shorten Dying Patients Lives
5. Patients With Filariasis More Prone To HIV Infection
6. Glivec - New Hope For CMC Patients
7. HIV infected patients can travel safely abroad
8. New vaccine helps allergy and asthma patients
9. Doctors operate upon patients in candlelight- latest from the quake scene
10. New vaccine helps allergy and asthma patients
11. Are cancer patients being taken for a ride?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... M&S ... Certificate of Conformity for the Smart System® 20/20. CE Certification builds upon M&S's ... standards and specifications such as ANSI, ISO and proven test methods used in ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer ... stages, is more than 95%. Once the cancer spreads to other organs, bones, or ... find out how to avoid this latter group, tune in to Lifestyle Magazine ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... ... at the GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate ... and will be an opportunity for area-residents to celebrate two great years while ...
(Date:3/25/2017)... PA (PRWEB) , ... March 25, 2017 , ... Getting ... as a public relations partner. , All through the year, Garden Media aims ... press releases, working with key influencers and pitching client’s key messages to ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... TEL AVIV, Israel , March 27, 2017 ... focused on oncology and immunology, announced today that AGI-134, an ... recently announced acquisition of Agalimmune Ltd., will be featured at ... Meeting in Washington, DC to ... ...
Breaking Medicine Technology: